Insulin action on heart and skeletal muscle FDG uptake in patients with hypertriglyceridemia

Journal of Nuclear Medicine

Volumn 40, Issue 7, 1999, Pages 1116-1121

  Yokoyama, Ikuo ^a   Ohtake, Tohru ^a   Momomura, Shin Ichi ^a   Yonekura, Katsunori ^a   Kobayakawa, Naoshi ^a   Aoyagi, Teruhiko ^a   Sugiura, Seiryo ^a   Yamada, Nobuhiro ^a   Ohtomo, Kuni ^a   Sasaki, Yasuhito ^a   Omata, Masao ^a   Yazaki, Yoshio ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Fluorodeoxy glucose; Heart and skeletal muscle glucose metabolism; Hypertriglyceridemia; Insulin resistance; PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE; INSULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG UPTAKE; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE METABOLISM; HEART MUSCLE; HUMAN; HYPERINSULINEMIA; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOISOTOPE DISTRIBUTION; SKELETAL MUSCLE;

CASE-CONTROL STUDIES; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; HEART; HUMANS; HYPERTRIGLYCERIDEMIA; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; MUSCLE, SKELETAL; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0033015787     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Ducimetiere P, Eschwege E, Papoz L, Richard JL, Claude JR, Rosselin G. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia. 1980;19:205-210.
2. Casassus P, Fontbonne A, Thibult N, et al. Upper-body fat distribution: a hyperinsulinemia-independent predictor of coronary heart disease mortality. The Paris Prospective Study. Arterioscler Thromb. 1992;12:1387-1392.
3. Feskens EJ, Kromhout D. Hyperinsulinemia, risk factors and coronary artery disease. Arterioscler Thromb. 1994;14:1641-1647.
4. Despres JP, Lamarche B, Mauriege P, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med. 1996;334:952-957.
5. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.
6. Defronzo RA, Gunnarsson R, Bjorkman O, Olson M, Wahren J. Effect of insulin on peripheral and splanchnic glucose metabolism in non-insulin dependent (type II) diabetes mellitus. j Clin Invest. 1985;76:149-155.
7. Kaplan NM. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 1989;149:514-520.
8. Steiner G, Morita S, Vranic M. Resistance to insulin but not to glucagon in lean human hypertriglyceridemics. Diabetes. 1980;29:899-905.
9. Bazelmans J, Nestel PJ, Nolan C. Insulin induced glucose utilization influences triglyceride metabolism. Clin Sci. 1983;64:511-516.
10. Reaven GM, Meheab K, Villaume C, Drouin P, Debry G. Plasma glucose and insulin responses to oral glucose in nonobese subjects and patients with endogeneous hypertriglyceridemia. Metabolism. 1983;32:447-450.
11. Yki-Jaervinen H, Taskinen M-R. Interrelationships among insulin's antilipolytic and glucoregulatory effects and plasma triglycerides in nondiabetic patients with endogenous hypertriglyceridemia. Diabetes. 1988;37:1271-1278.
12. McKane WR, Stevens AB, Woods R, Andrews WJ, Henry RW, Bell PM. The assessment of hepatic and peripheral insulin sensitivity in hypertriglyceridemia. Metabolism. 1990;39:1240-1245.
13. Widen E, Ekstrand A, Saloranta C, et al. Insulin resistance in type 2 (non-insulin-dependent) diabetic patients with hypertriglyceridemia. Diabetologia. 1992;35: 1140-1145.
14. Suzuki K, Kono T. Evidence that insulin causes translocation of glucose transport activity to the plasma membrane from an intracellular storage site. Proc Natl Acad Sci USA. 1980;77:2542-2545.
15. Bonadonna RC, Saccomani MO, Seely L, et al. Glucose transport in human skeletal muscle: the in vivo response to insulin. Diabetes. 1993;42:191-198.
16. Hickey MS, Carey JO, Azevedo JL, et al. Skeletal muscle fiber composition is related to adiposity and in vitro glucose transport rate in humans. Am J Physiol: Endocrinol Metab. 1995;268:E453-E457.
17. Ng CK, Holden JE, Degrado TR, Raffel DM, Komguth ML, Gateley SJ. Sensitivity of myocardial fluorodeoxyglucose lumped constant to glucose and insulin. Am J Physiol: Heart Circ Physiol. 1991;260:H593-H603.
18. Chung JY, Conover C, Regan DM, Whitefield CF, Morgan HE. Effect of insulin on kinetics of sugar transport in heart muscle. Am J Physiol. 1978;234:E70-E78.
19. Morgan HE, Henderson MJ, Park CR. Regulation of glucose uptake in muscle. The effects of insulin and anoxia on glucose transport and phosphorylation in the isolated, reperfused heart of normal rats. J Biol Chem. 1961;236:253-261.
20. Barrett E, Schwartz RG, Francis CK, Zaret BL. Regulation by insulin of myocardial glucose and fatty acid metabolism in the conscious dog. J Clin Invest. 1984;74:1073-1079.
21. Ferrannini E, Barrett EJ, Bevilacqua S, DeFronzo RA. Effect of fatty acids on glucose production and utilization in man. J Clin Invest. 1983;72:1737-1747.
22. Barrett E, Schwartz RG, Young LH, Jacob R, Zaret BL. Effect of chronic diabetes on myocardial fuel metabolism and insulin sensitivity. Diabetes. 1988;37:943-948.
23. Kim JK, Youn JH. Plasma free fatty acids decrease insulin stimulated skeletal muscle glucose uptake by suppressing glycolysis in conscious rats. Diabetes. 1996;45:446-453.
24. 18F]fluorodeoxyglucose. J Nucl Cardiol. 1997;4:125-132.
25. Ng CK, Soufer R, McNulty PH. Effect of hyperinsulinemia on myocardial fluorine-18-FDG uptake. J Nucl Med 1998;39:379-383.
26. 14C) deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem. 1977;28:897-916.
27. Phelps ME, Hoffman EJ, Selin CE, et al. Investigation of (F-18)2-fluoro-2-deoxyglucose for the measurement of myocardial glucose metabolism. J Nucl Med. 1978;19:1311-1319.
28. Patlack CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood to brain transfer contents from multiple time uptake data. J Cereb Blood Flow Metab. 1983;3:1-7.
29. 18F)-D-glucose transport and phosphorylation rates in myocardium using dual-tracer kinetic experiments. FEBS Lett. 1987;216:128-132.
30. Ohtake T, Kosaka N, Watanabe T, et al. Noninvasive method to obtain input function for measuring tissue glucose utilization of thoracic and abdominal organs. J Nucl Med. 1991;32:1432-1438.
31. Raitib O, Phelps ME, Huang SC, Henze E, Selin CE, Scherbert HR. Positron tomography with deoxyglucose for estimating local myocardial glucose metabolism. J Nucl Med. 1982;23:577-586.
32. Gambihir SS, Schwaiger M, Huang SC, et al. Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18-deoxyglucose. J Nucl Med. 1989;30:359-366.
33. 3. N Engl J Med. 1986;314:884-888.
34. Tamaki N, Yonekura Y, Yamashita K, et al. Positron emission tomography using fluorine-18 deoxyglucose in evaluation of coronary artery bypass grafting. Am J Cardiol. 1989;64:860-865.
35. Voipio-Pulkki LM, Nuutila P, Knuuti MJ, et al. Heart and skeletal muscle glucose disposal in type 2 diabetic patients as determined by positron emission tomography. J Nucl Med. 1993;34:2064-2067.
36. Ohtake T, Yokoyama I, Watanabe T, et al. Myocardial glucose metabolism in noninsulin dependent diabetes mellitus patients evaluated by FDG-PET. J Nucl Med. 1995;36:456-463.
37. Nuutila P, Maeki M, Laine H, et al. Insulin action on heart and skeletal muscle glucose uptake in essential hypertension. J Clin Invest. 1995;96:1003-1009.
38. Yokoyama I, Ohtake T, Momomura S, et al. Organ specific insulin resistance in patients with non-insulin dependent diabetes mellitus and hypertension. J Nucl Med. 1998;39:884-889.
39. Ehrenkaufer RL, Potocki JF, Jewett DM. Simple synthesis of F-18 labeled 2-fluoro-2-deoxy-D-glucose. J Nucl Med. 1984;25:333-337.
40. Yokoyama I, Ohtake T, Momomura S, et al. Hyperglycemia rather than insulin resistance is related to the coronary flow reserve in patients with non-insulin dependent diabetes mellitus. Diabetes. 1998;47:119-124.
41. Hicks RJ, Herman WH, Kalff V, et al. Quantitative evaluation of regional substrate metabolism in the human heart by positron emission tomography. J Am Coll Cardiol. 1991;18:101-110.
42. vom Dahl J, Herman WH, Hicks RJ, et al. Myocardial glucose uptake in patients with insulin-dependent diabetes mellitus assessed quantitatively by dynamic positron emission tomography. Circulation. 1993;88:395-404.
43. Nuutila P, Koivisto VA, Knuuti J, et al. Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo. J Clin Invest. 1992;89:1767-1774.
44. Maki M, Nuutila P, Laine H, et al. Myocardial glucose uptake in patients with NIDDM and stable coronary artery disease. Diabetes. 1997;46:1491-1496.
45. Yokoyama I, Ohtake T, Momomura S, et al. Improvement of left ventricular function in patients with idiopathic dilated cardiomyopathy predicted by positron emission tomography using F(18)-fluorine-fluoro-2-deoxy-glucose. Eur J Nucl Med. 1998;25:736-743.
46. Knuuti MJ, Nuutila P, Ruotsalainen U, et al. Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron-emission tomography. J Nucl Med. 1992;33:1255-1262.
47. 18F]2-deoxy-2-fluoro-D-glucose for assessing myocardial glucose uptake. Circulation. 1995;91:2435-2444.